BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27917904)

  • 21. Survival benefit of greater number of lymph nodes dissection for advanced node-negative gastric cancer patients following radical gastrectomy.
    He H; Shen Z; Wang X; Qin J; Sun Y; Qin X
    Jpn J Clin Oncol; 2016 Jan; 46(1):63-70. PubMed ID: 26497044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
    Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
    Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is it worthy of adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for distal gastric cancers with No. 6 lymph node metastasis?
    Zhang J; Zou S; Luo R; Zhu Z; Wang Z; Xu H; Huang B
    Clin Transl Oncol; 2019 Dec; 21(12):1699-1706. PubMed ID: 30977046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of oxaliplatin in the adjuvant setting of different Lauren's type of gastric adenocarcinoma after D2 gastrectomy: a real-world study.
    Cheng X; Yu S; Wang Y; Cui Y; Li W; Yu Y; Tang C; Jiang H; Ji Y; Sun Y; Wang X; Shen Z; Liu F; Liu TS
    Gastric Cancer; 2019 May; 22(3):587-597. PubMed ID: 30426294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
    Xie J; Pang Y; Li X; Wu X
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-infiltrating Neutrophils is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer.
    Zhang H; Liu H; Shen Z; Lin C; Wang X; Qin J; Qin X; Xu J; Sun Y
    Ann Surg; 2018 Feb; 267(2):311-318. PubMed ID: 27763900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
    Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncologic outcomes of laparoscopy-assisted distal gastrectomy for gastric cancer.
    Fukunaga T; Hiki N; Kubota T; Nunobe S; Tokunaga M; Nohara K; Sano T; Yamaguchi T
    Ann Surg Oncol; 2013 Aug; 20(8):2676-82. PubMed ID: 23709054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center.
    Kano Y; Ohashi M; Hiki N; Takahari D; Chin K; Yamaguchi K; Tsuda Y; Shoji Y; Yasufuku I; Eto K; Ida S; Kumagai K; Nunobe S; Sano T
    Gastric Cancer; 2018 Nov; 21(6):1024-1030. PubMed ID: 29700635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of risk factors and prognosis of No.8p lymph node metastasis in cases with advanced gastric cancer].
    Chen L; Wei S; Ye Z; Zeng Y; Zheng Q; Xiao J; Wang Y; Zhuo C; Lin Z; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):218-223. PubMed ID: 28226359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer.
    Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Lee JH; Kim YS
    J Surg Res; 2010 Aug; 162(2):177-83. PubMed ID: 20031164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [GRP78 expression in gastric cancer and its clinical significance].
    Yang L; Yang SY; Ji JM; Cao YF; Ji CF; Ji JF; Xu WW; Wang JH
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):837-42. PubMed ID: 24447482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of spleen-preserving lymphadenectomy in total gastrectomy for gastric and esophagogastric junctional adenocarcinomas: A long-term retrospective propensity score match study from a high-volume institution in China.
    Liu K; Chen XZ; Zhang YC; Zhang WH; Chen XL; Sun LF; Yang K; Zhang B; Zhou ZG; Hu JK
    Surgery; 2021 Feb; 169(2):426-435. PubMed ID: 32950240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
    Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinicopathological features and survival analysis of gastric cancer patients with neuroendocrine differentiation after radical resection].
    Yu S; Lyu MZ; Luo RK; Liu FL; Liu TS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):426-432. PubMed ID: 34000772
    [No Abstract]   [Full Text] [Related]  

  • 36. Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer.
    Bilici A; Seker M; Ustaalioglu BB; Yilmaz B; Doventas A; Salepci T; Gumus M
    Med Oncol; 2010 Sep; 27(3):975-84. PubMed ID: 19885750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile?
    Yildirim E; Celen O; Berberoglu U
    J Am Coll Surg; 2001 Jan; 192(1):25-37. PubMed ID: 11192920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience.
    Galizia G; Lieto E; Auricchio A; Cardella F; Mabilia A; Diana A; Castellano P; De Vita F; Orditura M
    PLoS One; 2017; 12(4):e0173619. PubMed ID: 28380037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
    Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
    Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
    World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.